Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01244711 · ClinicalTrials.gov registry record · Phase 4
Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT01244711 is a Phase 4 study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 1 participants.
The verdict
NCT01244711, a Phase 4 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
The hypothesis of this study is that symptoms of anxiety, depression and insomnia; and indices of psychosocial function will all improve, while BZ use will decrease significantly during a twelve-week trial period of substituting quetiapine for benzodiazepines.
Interventions
- DRUG quetiapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01244711
The ClinicalTrials.gov registry entry for NCT01244711 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which quetiapine is the first listed.
NCT01244711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01244711 about?
NCT01244711 is a clinical study titled "Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines". The hypothesis of this study is that symptoms of anxiety, depression and insomnia; and indices of psychosocial function will all improve, while BZ use will decrease significantly during a twelve-week trial period of substituting quetiapine for benzodiazepines.
What is the current status of trial NCT01244711?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2008-09. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01244711?
The interventions under investigation include: quetiapine (DRUG).
Who is sponsoring clinical trial NCT01244711?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.